Publications by authors named "Udi Ghitza"

Claim this Profile
H
Hospital Provider's Perspectives on MOUD Initiation and Continuation After Inpatient Discharge.
Riley Shearer, Honora Englander, Hildi Hagedorn, Adetayo Fawole, JoAn Laes, Udi Ghitza

J Gen Intern Med· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Research agenda evaluating measurement-based care for opioid use disorder among patients with co-occurring depressive disorders.
Udi E Ghitza

Front Psychiatry· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized, placebo-controlled trial of injectable extended-release naltrexone and injectable extended-release buprenorphine for cocaine use disorder (CURB-2): Study rationale and design.
Madhukar H Trivedi, Mariah M Kalmin, Thomas Carmody, Edward M Chongsi, Udi E Ghitza

Contemp Clin Trials· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Craving, Impulsivity, and Subsequent Methamphetamine Use With Naltrexone-Bupropion Versus Placebo: Findings From a Randomized Clinical Trial.
Manish K Jha, Udi E Ghitza, Thomas Carmody, Snoben Kuruvila, Steven Shoptaw

J Addict Med· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Change in Depressive Symptom Severity With Naltrexone-Bupropion Combination and Its Association With Reduction in Methamphetamine Use in ADAPT-2 Trial.
Manish K Jha, Udi E Ghitza, Steve Shoptaw, Abu Minhajuddin, Snoben Kuruvila

J Clin Psychiatry· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Artificial intelligence-based drug repurposing with electronic health record clinical corroboration: A case for ketamine as a potential treatment for amphetamine-type stimulant use disorder.
Zhenxiang Gao, T John Winhusen, Maria P Gorenflo, Ian Dorney, Udi E Ghitza

Addiction· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Barriers and facilitators to implementing treatment for opioid use disorder in community hospitals.
Riley Shearer, Hildi Hagedorn, Honora Englander, Tracy Siegler, Roxanne Kibben, Udi Ghitza

J Subst Use Addict Treat· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exemplar Hospital Initiation Trial to Enhance Treatment Engagement (EXHIT ENTRE): protocol for CTN-0098 an open-label randomized comparative effectiveness trial of extended-release buprenorphine versus treatment as usual on post-hospital treatment engagement for hospitalized patients with opioid use disorder.
Gavin Bart, Kelly S Barth, Paulette Baukol, Eva Enns, Udi E Ghitza

Addict Sci Clin Pract· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Delivering MOUD to the Underserved: How Can Pharmacies Really Help?
David H Gustafson, Todd Molfenter, Thomas Kunes, Lisa Langdon, Michael Koplin, Udi Ghitza

J Stud Alcohol Drugs· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid Initiation of Injection Naltrexone for Opioid Use Disorder: A Stepped-Wedge Cluster Randomized Clinical Trial.
Matisyahu Shulman, Miranda G Greiner, Hiwot M Tafessu, Onumara Opara, Kaitlyn Ohrtman, Udi E Ghitza

JAMA Netw Open· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exemplar Hospital initiation trial to Enhance Treatment Engagement (EXHIT ENTRE): protocol for CTN-0098B a randomized implementation study to support hospitals in caring for patients with opioid use disorder.
Gavin Bart, P Todd Korthuis, Julie M Donohue, Hildi J Hagedorn, Dave H Gustafson, Udi E Ghitza

Addict Sci Clin Pract· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementing a pharmacist-integrated collaborative model of medication treatment for opioid use disorder in primary care: study design and methodological considerations.
Bethany McLeman, Phoebe Gauthier, Laurie S Lester, Felicity Homsted, Vernon Gardner, Udi Ghitza

Addict Sci Clin Pract· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential effect of antidepressants on remission from cocaine use disorder - A nationwide matched retrospective cohort study.
Zhenxiang Gao, T John Winhusen, Maria Gorenflo, Udi E Ghitza, Edward Nunes

Drug Alcohol Depend· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Research Priorities for Expansion of Opioid Use Disorder Treatment in the Community Pharmacy.
Jennie B Jarrett, Jeffrey Bratberg, Anne L Burns, Gerald Cochran, Bethany A DiPaula, Udi E Ghitza

Subst Abus· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Repurposing ketamine to treat cocaine use disorder: integration of artificial intelligence-based prediction, expert evaluation, clinical corroboration and mechanism of action analyses.
Zhenxiang Gao, T John Winhusen, Maria Gorenflo, Udi E Ghitza, Pamela B Davis

Addiction· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Buprenorphine use and courses of care for opioid use disorder treatment within the Veterans Health Administration.
Adam J Gordon, Andrew J Saxon, Stefan Kertesz, Jessica J Wyse, Ajay Manhapra, Udi E Ghitza

Drug Alcohol Depend· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surmounting Withdrawal to Initiate Fast Treatment with Naltrexone (SWIFT): A stepped wedge hybrid type 1 effectiveness-implementation study.
Miranda G Greiner, Matisyahu Shulman, Onumara Opara, Kenzie Potter, Delia C Voronca, Udi E Ghitza

Contemp Clin Trials· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The opioid use disorder core outcomes set (OUD-COS) for treatment research: findings from a Delphi consensus study.
Niranjan S Karnik, John Marsden, Connor McCluskey, Randy A Boley, Katharine A Bradley, Udi Ghitza

Addiction· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pain Severity and Interference and Substance Use Among Community Pharmacy Patients Prescribed Opioids: A Secondary Analysis of the PHARMSCREEN Study.
Elizabeth Charron, Akiko Okifuji, M Aryana Bryan, Sarah Reese, Jennifer L Brown, Udi E Ghitza

J Pain· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between treatment setting and outcomes among oregon medicaid patients with opioid use disorder: a retrospective cohort study.
Daniel M Hartung, Sheila Markwardt, Kirbee Johnston, Jonah Geddes, Robin Baker, Udi Ghitza

Addict Sci Clin Pract· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Medical Cannabis Use Reported on a Confidential Survey vs Documented in the Electronic Health Record Among Primary Care Patients.
Gwen T Lapham, Theresa E Matson, David S Carrell, Jennifer F Bobb, Casey Luce, Udi E Ghitza

JAMA Netw Open· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical documentation of patient-reported medical cannabis use in primary care: Toward scalable extraction using natural language processing methods.
David S Carrell, David J Cronkite, Mary Shea, Malia Oliver, Casey Luce, Udi E Ghitza

Subst Abus· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation and threshold identification of a prescription drug monitoring program clinical opioid risk metric with the WHO alcohol, smoking, and substance involvement screening test.
Gerald Cochran, Jennifer Brown, Ziji Yu, Stacey Frede, M Aryana Bryan, Udi E Ghitza

Drug Alcohol Depend· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concomitant Cannabis Misuse and Associations with Depression, Pain and Substance Misuse among Patients Prescribed Opioids.
M Aryana Bryan, Elizabeth Charron, Omolola Adeoye-Olatunde, Jennifer Brown, Udi Ghitza

Pharmacy (Basel)· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Examination of the Feasibility of Detecting Cocaine Use Using Smartwatches.
Emre Ertin, Nithin Sugavanam, August F Holtyn, Kenzie L Preston, Jeremiah W Bertz, Udi E Ghitza

Front Psychiatry· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis